Last reviewed 2026-04-19 · How we verify

Pasireotide ampule with syringe

RECORDATI GROUP · Phase 1 active Small molecule

Pasireotide ampule with syringe is a Small molecule drug developed by RECORDATI GROUP. It is currently in Phase 1 development.

At a glance

Generic name	Pasireotide ampule with syringe
Sponsor	RECORDATI GROUP
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pasireotide ampule with syringe CI brief — competitive landscape report
Pasireotide ampule with syringe updates RSS · CI watch RSS
RECORDATI GROUP portfolio CI

Frequently asked questions about Pasireotide ampule with syringe

What is Pasireotide ampule with syringe?

Pasireotide ampule with syringe is a Small molecule drug developed by RECORDATI GROUP.

Who makes Pasireotide ampule with syringe?

Pasireotide ampule with syringe is developed by RECORDATI GROUP (see full RECORDATI GROUP pipeline at /company/recordati-group).

What development phase is Pasireotide ampule with syringe in?

Pasireotide ampule with syringe is in Phase 1.

Manufacturer: RECORDATI GROUP — full pipeline
Compare: Pasireotide ampule with syringe vs similar drugs
Pricing: Pasireotide ampule with syringe cost, discount & access